{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:05:11Z","timestamp":1776297911078,"version":"3.50.1"},"reference-count":48,"publisher":"The Endocrine Society","issue":"10","license":[{"start":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T00:00:00Z","timestamp":1659484800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,9,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>Noninvasive encapsulated follicular variant of papillary thyroid cancer was reclassified as noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) in January 2017. The impact of this nomenclature change at a population level remains unknown.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Examine use of NIFTP across different US regions and populations.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>Descriptive epidemiology study using SEER-22 data (2000-2019).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Participants<\/jats:title>\n                  <jats:p>Individuals diagnosed with papillary or follicular thyroid cancer (2000-2019) or NIFTP (2017-2019).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Main Outcome Measures<\/jats:title>\n                  <jats:p>Annual incidence rates of thyroid cancer by subtype and NIFTP. Using 2018-2019 data, (1) rates of NIFTP at the 17 SEER-22 sites and (2) comparison of demographics for patients diagnosed with NIFTP vs papillary and follicular thyroid cancer.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>NIFTP comprised 2.2% and 2.6% of cases in 2018 and 2019, respectively. Between 2018 and 2019, large heterogeneity was observed in the regional use of NIFTP diagnosis, with site-specific incidence rates between 0.0% and 6.2% (median 2.8%, interquartile range 1.3-3.6%). A diagnosis of NIFTP (vs papillary and follicular thyroid cancer) in 2018 and 2019 was significantly associated with older age (P\u2005=\u20050.012 and P\u2005=\u20050.009, respectively), Black race (both Ps\u2005&amp;lt;\u20050.001), and non-Hispanic ethnicity (both Ps\u2005&amp;lt;\u20050.001).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Marked variation exists in the use of the NIFTP diagnosis. The recent 2021 coding change that resulted in NIFTP, a tumor with uncertain malignant potential and for which there is no long-term outcome data available, no longer being a reportable diagnosis to SEER will disproportionately affect vulnerable patient groups such as older patients and Black patients, in addition to patients who reside in regions with higher rates of NIFTP diagnoses.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/clinem\/dgac466","type":"journal-article","created":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T02:51:34Z","timestamp":1659495094000},"page":"e4072-e4077","source":"Crossref","is-referenced-by-count":10,"title":["Variation in the Diagnosis of Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features"],"prefix":"10.1210","volume":"107","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6562-7232","authenticated-orcid":false,"given":"Debbie W","family":"Chen","sequence":"first","affiliation":[{"name":"Division of Metabolism, Endocrinology, and Diabetes, University of Michigan , Ann Arbor, MI , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farizah I","family":"Rob","sequence":"additional","affiliation":[{"name":"University of Michigan College of Literature, Science and the Arts , Ann Arbor, MI , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rik","family":"Mukherjee","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, University of Michigan , Ann Arbor, MI , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas J","family":"Giordano","sequence":"additional","affiliation":[{"name":"Division of Metabolism, Endocrinology, and Diabetes, University of Michigan , Ann Arbor, MI , USA"},{"name":"Department of Pathology, University of Michigan , Ann Arbor, MI , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1083-1575","authenticated-orcid":false,"given":"Megan R","family":"Haymart","sequence":"additional","affiliation":[{"name":"Division of Metabolism, Endocrinology, and Diabetes, University of Michigan , Ann Arbor, MI , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mousumi","family":"Banerjee","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, University of Michigan , Ann Arbor, MI , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2022,8,3]]},"reference":[{"key":"2022092808412607900_CIT0001","author":"North American Association of Central Cancer Registries"},{"issue":"8","key":"2022092808412607900_CIT0002","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1001\/jamaoncol.2016.0386","article-title":"Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma: a paradigm shift to reduce overtreatment of indolent tumors","volume":"2","author":"Nikiforov","year":"2016","journal-title":"JAMA Oncol."},{"key":"2022092808412607900_CIT0003","author":"North American Association of Central Cancer Registries"},{"key":"2022092808412607900_CIT0004","author":"Kolata"},{"key":"2022092808412607900_CIT0005","author":"National Institutes of Health"},{"issue":"6","key":"2022092808412607900_CIT0006","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1097\/PAS.0b013e3181dbee07","article-title":"Encapsulated well-differentiated follicular-patterned thyroid carcinomas do not play a significant role in the fatality rates from thyroid carcinoma","volume":"34","author":"Piana","year":"2010","journal-title":"Am J Surg Pathol."},{"issue":"3","key":"2022092808412607900_CIT0007","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1089\/thy.2012.0369","article-title":"Risk stratification of follicular variant of papillary thyroid carcinoma","volume":"23","author":"Vivero","year":"2013","journal-title":"Thyroid."},{"issue":"5","key":"2022092808412607900_CIT0008","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.humpath.2015.01.010","article-title":"Invasion rather than nuclear features correlates with outcome in encapsulated follicular tumors: further evidence for the reclassification of the encapsulated papillary thyroid carcinoma follicular variant","volume":"46","author":"Ganly","year":"2015","journal-title":"Hum Pathol."},{"issue":"4","key":"2022092808412607900_CIT0009","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/cen.12387","article-title":"Noninvasive encapsulated follicular variant of papillary thyroid carcinoma: is lobectomy sufficient for tumours \u22651 cm?","volume":"81","author":"Rosario","year":"2014","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"4","key":"2022092808412607900_CIT0010","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/his.12680","article-title":"Absence of BRAF V600E in non-infiltrative, non-invasive follicular variant of papillary thyroid carcinoma","volume":"67","author":"Howitt","year":"2015","journal-title":"Histopathology."},{"issue":"1","key":"2022092808412607900_CIT0011","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1349-7006.2010.01769.x","article-title":"Encapsulated follicular thyroid tumor with equivocal nuclear changes, so-called well-differentiated tumor of uncertain malignant potential: a morphological, immunohistochemical, and molecular appraisal","volume":"102","author":"Liu","year":"2011","journal-title":"Cancer Sci."},{"issue":"2","key":"2022092808412607900_CIT0012","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00268-017-4182-5","article-title":"Clinical safety of renaming encapsulated follicular variant of papillary thyroid carcinoma: is NIFTP truly benign?","volume":"42","author":"Parente","year":"2018","journal-title":"World J Surg."},{"issue":"6","key":"2022092808412607900_CIT0013","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/modpathol.2017.9","article-title":"Molecular correlates and rate of lymph node metastasis of non-invasive follicular thyroid neoplasm with papillary-like nuclear features and invasive follicular variant papillary thyroid carcinoma: the impact of rigid criteria to distinguish non-invasive follicular thyroid neoplasm with papillary-like nuclear features","volume":"30","author":"Cho","year":"2017","journal-title":"Mod Pathol."},{"issue":"4","key":"2022092808412607900_CIT0014","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1089\/thy.2016.0649","article-title":"Outcome of large noninvasive follicular thyroid neoplasm with papillary-like nuclear features","volume":"27","author":"Xu","year":"2017","journal-title":"Thyroid."},{"issue":"12","key":"2022092808412607900_CIT0015","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1530\/ERC-16-0379","article-title":"Noninvasive follicular thyroid neoplasm with papillary-like nuclear features","volume":"23","author":"Rosario","year":"2016","journal-title":"Endocr Relat Cancer."},{"issue":"7","key":"2022092808412607900_CIT0016","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/modpathol.2016.65","article-title":"Ninety-four cases of encapsulated follicular variant of papillary thyroid carcinoma: a name change to noninvasive follicular thyroid neoplasm with papillary-like nuclear features would help prevent overtreatment","volume":"29","author":"Thompson","year":"2016","journal-title":"Mod Pathol."},{"issue":"1","key":"2022092808412607900_CIT0017","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s12902-021-00883-7","article-title":"Bone metastasis from noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): a case report","volume":"21","author":"Fakhar","year":"2021","journal-title":"BMC Endocr Disord."},{"issue":"8","key":"2022092808412607900_CIT0018","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1001\/jamaoncol.2018.1446","article-title":"Change in diagnostic criteria for noninvasive follicular thyroid neoplasm with papillarylike nuclear features","volume":"4","author":"Nikiforov","year":"2018","journal-title":"JAMA Oncol."},{"issue":"1","key":"2022092808412607900_CIT0019","doi-asserted-by":"crossref","first-page":"27","DOI":"10.17140\/OTLOJ-3-137","article-title":"NIFTP: a critical pathologist view","volume":"3","author":"Le\u00e3o","year":"2017","journal-title":"Otolaryngol Open J."},{"issue":"1","key":"2022092808412607900_CIT0020","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1309\/P7QL-16KQ-QLF4-XW0M","article-title":"Strict criteria should be applied in the diagnosis of encapsulated follicular variant of papillary thyroid carcinoma","volume":"117","author":"Chan","year":"2002","journal-title":"Am J Clin Pathol."},{"issue":"5","key":"2022092808412607900_CIT0021","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1309\/AJCPKP2QUVN4RCCP","article-title":"Interobserver and intraobserver variation among experts in the diagnosis of thyroid follicular lesions with borderline nuclear features of papillary carcinoma","volume":"130","author":"Elsheikh","year":"2008","journal-title":"Am J Clin Pathol."},{"issue":"10","key":"2022092808412607900_CIT0022","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1097\/01.pas.0000135519.34847.f6","article-title":"Observer variation in the diagnosis of follicular variant of papillary thyroid carcinoma","volume":"28","author":"Lloyd","year":"2004","journal-title":"Am J Surg Pathol."},{"issue":"4","key":"2022092808412607900_CIT0023","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/pin.12779","article-title":"Interobserver and intraobserver variation in the morphological evaluation of noninvasive follicular thyroid neoplasm with papillary-like nuclear features in Asian practice","volume":"69","author":"Liu","year":"2019","journal-title":"Pathol Int."},{"issue":"11","key":"2022092808412607900_CIT0024","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1097\/00000478-200211000-00014","article-title":"Observer variation of encapsulated follicular lesions of the thyroid gland","volume":"26","author":"Hirokawa","year":"2002","journal-title":"Am J Surg Pathol."},{"issue":"1","key":"2022092808412607900_CIT0025","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.surg.2018.04.089","article-title":"NIFT-P: Are they indolent tumors? Results of a multi-institutional study","volume":"165","author":"Chereau","year":"2019","journal-title":"Surgery."},{"key":"2022092808412607900_CIT0026","author":"Surveillance, Epidemiology, and End Results Program"},{"issue":"12","key":"2022092808412607900_CIT0027","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa690","article-title":"Influence of nomenclature changes on trends in papillary thyroid cancer incidence in the United States, 2000 to 2017","volume":"105","author":"Kitahara","year":"2020","journal-title":"J Clin Endocrinol Metab."},{"issue":"8","key":"2022092808412607900_CIT0028","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1089\/thy.2019.0415","article-title":"Thyroid cancer incidence trends in the United States: association with changes in professional guideline recommendations","volume":"30","author":"Pereira","year":"2020","journal-title":"Thyroid."},{"issue":"10","key":"2022092808412607900_CIT0029","first-page":"1502","article-title":"The incidence of noninvasive follicular thyroid neoplasm with papillary-like nuclear features: a meta-analysis assessing worldwide impact of the reclassification","volume":"31","author":"Rana","year":"2021","journal-title":"Thyroid."},{"key":"2022092808412607900_CIT0030","author":"Surveillance, Epidemiology, and End Results Program"},{"key":"2022092808412607900_CIT0031","author":"Surveillance, Epidemiology, and End Results Program"},{"issue":"12","key":"2022092808412607900_CIT0032","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1097\/PAS.0000000000000749","article-title":"The Surveillance, Epidemiology, and End Results (SEER) program and pathology: toward strengthening the critical relationship","volume":"40","author":"Duggan","year":"2016","journal-title":"Am J Surg Pathol."},{"key":"2022092808412607900_CIT0033","volume-title":"SEER Program Coding and Staging Manual 2022","author":"Adamo","year":"2021"},{"key":"2022092808412607900_CIT0034","author":"Surveillance, Epidemiology, and End Results Program"},{"issue":"1","key":"2022092808412607900_CIT0035","first-page":"26","article-title":"Effect of lowering the diagnostic threshold for encapsulated follicular variant of papillary thyroid carcinoma on the prevalence of non-invasive follicular thyroid neoplasm with papillary-like nuclear features: a single-institution experience in Korea","volume":"6","author":"Jung","year":"2017","journal-title":"J Basic Clin Med."},{"key":"2022092808412607900_CIT0036","doi-asserted-by":"crossref","first-page":"151439","DOI":"10.1016\/j.anndiagpath.2019.151439","article-title":"Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) is rare, benign lesion using modified stringent diagnostic criteria: reclassification and outcome study","volume":"44","author":"Rego","year":"2020","journal-title":"Ann Diagn Pathol."},{"issue":"12","key":"2022092808412607900_CIT0037","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1001\/jamaoto.2014.1745","article-title":"Association of socioeconomic status, race, and ethnicity with outcomes of patients undergoing thyroid surgery","volume":"140","author":"Hauch","year":"2014","journal-title":"JAMA Otolaryngol Head Neck Surg."},{"issue":"7","key":"2022092808412607900_CIT0038","doi-asserted-by":"crossref","first-page":"808","DOI":"10.4158\/EP171788.OR","article-title":"Referral of older thyroid cancer patients to a high-volume surgeon: results of a multidisciplinary physician survey","volume":"23","author":"Papaleontiou","year":"2017","journal-title":"Endocr Pract."},{"issue":"9","key":"2022092808412607900_CIT0039","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1089\/thy.2020.0166","article-title":"Disparities research in thyroid cancer: challenges and strategies for improvement","volume":"30","author":"Chen","year":"2020","journal-title":"Thyroid."},{"issue":"1","key":"2022092808412607900_CIT0040","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1210\/jc.2013-2781","article-title":"Racial and socioeconomic disparities in presentation and outcomes of well-differentiated thyroid cancer","volume":"99","author":"Harari","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"issue":"8","key":"2022092808412607900_CIT0041","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1245\/s10434-014-3610-0","article-title":"The impact of surgical volume on racial disparity in thyroid and parathyroid surgery","volume":"21","author":"Noureldine","year":"2014","journal-title":"Ann Surg Oncol."},{"issue":"6","key":"2022092808412607900_CIT0042","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1097\/SLA.0b013e31812eecc4","article-title":"Racial disparities in clinical and economic outcomes from thyroidectomy","volume":"246","author":"Sosa","year":"2007","journal-title":"Ann Surg."},{"issue":"3","key":"2022092808412607900_CIT0043","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/lary.25606","article-title":"Outcomes in endocrine cancer surgery are affected by racial, economic, and healthcare system demographics","volume":"126","author":"Al-Qurayshi","year":"2016","journal-title":"Laryngoscope."},{"issue":"2","key":"2022092808412607900_CIT0044","first-page":"210","article-title":"Outcomes of thyroid cancer in African Americans","volume":"21","author":"Hollenbeak","year":"2011","journal-title":"Ethn Dis."},{"key":"2022092808412607900_CIT0045","author":"Surveillance, Epidemiology, and End Results Program"},{"issue":"7","key":"2022092808412607900_CIT0046","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1001\/jamaoncol.2015.2607","article-title":"Rethinking the standard for Ductal carcinoma in situ treatment","volume":"1","author":"Esserman","year":"2015","journal-title":"JAMA Oncol."},{"issue":"5","key":"2022092808412607900_CIT0047","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv372","article-title":"Outcomes of active surveillance for ductal carcinoma in situ: a computational risk analysis","volume":"108","author":"Ryser","year":"2016","journal-title":"J Natl Cancer Inst."},{"issue":"3","key":"2022092808412607900_CIT0048","doi-asserted-by":"crossref","first-page":"e026797","DOI":"10.1136\/bmjopen-2018-026797","article-title":"The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a Phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS)","volume":"9","author":"Hwang","year":"2019","journal-title":"BMJ Open."}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgac466\/45417769\/dgac466.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/107\/10\/e4072\/46112683\/dgac466.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/107\/10\/e4072\/46112683\/dgac466.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T08:46:45Z","timestamp":1664354805000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/107\/10\/e4072\/6653515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,3]]},"references-count":48,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,8,3]]},"published-print":{"date-parts":[[2022,9,28]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgac466","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,10,1]]},"published":{"date-parts":[[2022,8,3]]}}}